Search clinical trials for: Hydroxyzine dihydrochloride

Total 272 results

Teva Pharmaceuticals USA

Completed

Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Mahidol University

Completed

Hydroxyzine for the Prevention of Pruritus From Spinal Morphine in Transabdominal Hysterectomy Patients (TAH)

Nausea | Vomiting | Pruritus

Thailand
Tongji University

Completed

The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION)

Pulmonary Hypertension

China
BioMarin Pharmaceutical

Completed

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

Phenylketonurias

United States
BioMarin Pharmaceutical

Completed

A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension

Hypertension

United States
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
OBEcure Ltd.
International Antiviral Therapy Evaluation Center

Completed

Efficacy Study of Betahistine on Body Weight in Obese Female Subjects

Obesity

Belgium, Germany, Netherlands
Inje University

Completed

The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects (CYP3APDE5I)

Healthy Subjects | Pharmacokinetics of Three PDE5Is | Genetic Polymorphic CYP3A5
University of Oxford
BioMarin Pharmaceutical

Unknown

Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

Coronary Artery Disease

United Kingdom
China Rehabilitation Research Center

Unknown

A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury (SCI)

Erectile Dysfunction

China
Rabin Medical Center

Unknown

Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.

Pulmonary Arterial Hypertension

Israel
BioMarin Pharmaceutical

Approved for marketing

Sapropterin Expanded Access Program

Phenylketonuria

United States
Biolipox AB

Completed

Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis

Allergic Rhinitis

Sweden
Bennett, James P., Jr., M.D., Ph.D.
University of Pittsburgh

Completed

R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
University Hospital Freiburg
University Hospital, Basel, Switzerland

Completed

Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride

Bacterial Infections | Bacteremia | Catheter-Associated Infections | Catheterization, Central Venous

Germany, Switzerland
Pfizer

Completed

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Breast Neoplasms

United States, Canada, Ireland, Italy, Sweden, Belgium, France, Spain, United Kingdom
BioMarin Pharmaceutical

Completed

Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria

Phenylketonurias

United States
Pfizer

Completed

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Lung Neoplasms

United States, Canada, Ireland, United Kingdom, Italy, Germany, Spain, Netherlands
J. Uriach and Company

Terminated

Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance

Healthy

Netherlands
BioStratum

Completed

Effect of Pyridorin in Patients With Diabetic Nephropathy

Diabetic Nephropathy
BioStratum

Completed

Effect of Pyridorin in Patients With Diabetic Nephropathy

Diabetic Nephropathy

3

Subscribe